Fagron NV
XBRU:FAGR
P/OCF
Price to OCF
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
Market Cap | P/OCF | ||||
---|---|---|---|---|---|
BE |
Fagron NV
XBRU:FAGR
|
1.4B EUR | 11 | ||
US |
Mckesson Corp
NYSE:MCK
|
73.9B USD | 17.1 | ||
US |
Cencora Inc
NYSE:COR
|
45.2B USD | 17.5 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 10.9 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
24.2B USD | 9.5 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 13.3 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | -320.2 | |
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
66B HKD | 3.6 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.5B EUR | 18.2 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
55.4B CNY | 15 | ||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
52.4B CNY | 22 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.